50% off the $29.99 Custom Kit. Use at checkout:
⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
AEO Score: 5.8/10
Monitoring for AI engine activity
In the Engagemii AEO index
#39,558 of 541,530 in Healthcare for AI visibility
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. Neuropathix, Inc. - Breakthrough Therapeutics Targeting Inflammation just got measured.
5.8/10 means Neuropathix, Inc. - Breakthrough Therapeutics Targeting Inflammation is somewhat visible. AI bots can read you, but you are missing the structured signals that would push citation rate above competitors.
Neuropathix, Inc. is a biopharmaceutical company focused on the research and development of a pipeline of next generation breakthrough therapeutics targeting inflammation to treat patients with significant unmet medical needs. Over the past ten years, Neuropathix has discovered, developed, and patented a global intellectual property estate, led by its lead clinical target, KLS-13019, as novel, new therapeutic agents designed to prevent and reverse neuropathic pain, reduce oxidative stress, and act as anti-inflammatory neuroprotectants. The Company's family of patented monotherapeutic molecules focuses on treating oxidative stress-related diseases, chronic pain management, and neurodegenerative disorders. Neuropathix conducts its research and development efforts at the Pennsylvania Biotechn
Industry: Healthcare
neuropathix.com2
Structured Data
4
Content Structure
6
Entity Clarity
5
E-E-A-T Signals
6
Technical AEO
4
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Neuropathix, Inc. - Breakthrough Therapeutics Targeting Inflammation.
Scored by Engagemii on July 4, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/neuropathix
Cite this score: Engagemii (2026). "AEO Score for Neuropathix, Inc. - Breakthrough Therapeutics Targeting Inflammation." Retrieved from https://engagemii.com/aeo/brands/neuropathix
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform
BMC (formerly BioMed Central) Journals
7.8/10
St. Jude Children's Research HospitalSt. Jude Children's Research Hospital logoSJ_ChildGraphic_Red_RGBSt. Jude Children's Research Hospital logo
7.8/10
University of Utah Healthcare
7.8/10
Harvard University Health Services
7.8/10
Department of Psychiatry and Behavioral Sciences
7.8/10
Stanford Health Library
7.8/10